Introduction
Every hemp brand is facing a version of the same strategic question as November 12 approaches: is our business more valuable if we reformulate our existing products to meet the new standard, reposition our brand around a different value proposition, or exit the market before the deadline forces the question?
There’s no universal right answer. The correct choice depends on your specific product portfolio, your customer base, your capitalization, your competitive position, and your team’s capacity to execute. But there is a framework for thinking through the decision clearly — and most brands that approach it systematically will find that one path has more signal behind it than the others.
Option 1: Reformulate — The Case For and Against
When reformulation is the right choice:
- Your core products can be brought into compliance without fundamentally changing what your customers value about them. A beverage that works as a 5mg delta-9 product may work as a 0.3mg total THC CBD-dominant product with the right formulation engineering.
- Your brand equity is built around the product experience (flavor, format, ritual) rather than the cannabinoid profile specifically. Consumers who love your beverage for how it tastes and makes them feel may migrate to a compliant version.
- You have the manufacturing flexibility and capital to execute reformulation on a timeline that reaches market before November 12.
- Your retail relationships are strong enough to hold shelf space through a product transition.
When reformulation is not the right choice:
- Your product’s value proposition is fundamentally about the psychoactive effect. A delta-8 gummy rebranded as a CBD gummy is not the same product, and your customers will know it.
- The economics don’t work. If your compliant reformulation can’t be priced competitively or can’t achieve the margin profile you need, reformulating extends the runway but doesn’t fix the business model.
- You don’t have the capital or manufacturing capacity to execute reformulation on the timeline November 12 requires.
Option 2: Rebrand — Building a Different Value Proposition
Rebranding is more than reformulation — it’s a strategic repositioning of what your brand stands for, who it serves, and what market it competes in.
When rebranding is the right choice:
- Your current brand is associated with intoxicating hemp products in a way that makes the compliance transition feel incoherent to your existing customers. A fresh brand built around verified, compliant hemp wellness creates a cleaner narrative than trying to explain why your hemp THC brand is now selling CBD products.
- You see a market opportunity in a segment your current brand can’t credibly serve — healthcare channels, professional wellness, functional food. A new brand built for that channel is a more convincing market entry than an existing intoxicating hemp brand trying to convert.
- You have the capital to invest in brand development and are willing to accept the lower initial awareness of a new brand in exchange for a cleaner positioning.
When rebranding is not the right choice:
- Your brand equity is real and transferable. If your customers know you, trust you, and will follow you through a product transition, rebranding throws away that equity unnecessarily.
- You don’t have the capital or timeline to build a new brand. Rebranding is a 12-18 month exercise at minimum. If you’re starting that process today, you won’t have meaningful brand presence by November 12.
Option 3: Exit — A Strategic Choice, Not a Failure
Exiting the hemp market before November 12 is a legitimate strategic decision, not necessarily a sign of defeat. The conditions under which exit makes the most sense:
Your business model depends on non-compliant products. If delta-8, THCA flower, or other products that will be prohibited post-November 12 are your primary revenue drivers, and compliant alternatives don’t exist at your required margin, exit before the deadline is more financially rational than fighting a compliance cliff.
Your capitalization doesn’t support the transition. Reformulation, testing, label changes, and distributor notification cost money. If your business doesn’t have the working capital to fund the transition and maintain operations simultaneously, an orderly exit now may preserve more value than a disorderly exit in November.
Better opportunities exist elsewhere. Some hemp brand operators have skills and relationships that are more valuable in adjacent markets — cannabis, functional foods, dietary supplements. Exiting the hemp market with your capital and team intact to pursue a better-positioned opportunity is a valid strategic choice.
What an orderly exit looks like: Maximizing inventory sell-through before November 12. Honoring existing retailer commitments. Managing supplier relationships professionally. Not acquiring new inventory you can’t sell. Communicating clearly and in advance with retail and distribution partners.
The Decision Framework: Three Questions
To determine which path is right for your business, answer three questions:
1. Is there a compliant version of your core product that can preserve 50% or more of your current customer value?
If yes, reformulation is likely viable. If no, you’re changing the product fundamentally, which may require rebranding or exit.
2. Do you have 6+ months of working capital to fund a transition while continuing operations?
If yes, reformulation or rebranding is executable. If no, the timeline may not be feasible, and exit may preserve more value.
3. Is your brand equity specific to your current product or transferable to a compliant product?
If transferable, reformulate under your existing brand. If your brand is associated with intoxicating products in ways your current customers value, rebranding or exit may be cleaner.
🌿 LGH Perspective
At Low Gravity Hemp, we work with brands across all three paths. For reformulators, we supply compliant ingredients with the formulation support to make the transition work. For brands building new compliant identities, we supply the ingredient quality that supports a premium positioning. For brands evaluating exit, we’re a resource for understanding what the compliant market looks like on the other side if they ever consider re-entry. Whatever path your brand is on, the ingredient infrastructure we provide is the same: verified, compliant, documented.
Final Thoughts
Reformulate, rebrand, or exit — there’s no shame in any of these choices, and there’s no formula that makes the decision for you. What the framework provides is a clear-eyed set of questions that cut through the uncertainty and point to the path that makes sense for your specific business.
The brands that make this decision deliberately and early will execute their chosen path more effectively than those who wait for the deadline to make the decision for them.
Contact Low Gravity Hemp to discuss compliant hemp ingredient sourcing for your reformulation or rebrand strategy.
